Cargando…
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
PURPOSE: Metformin is the first-line antidiabetic drug and shown to reduce cardiovascular risk independent from its glucose lowering action. Particularly in poorly controlled diabetes, tissue factor (TF) is expressed in the vasculature and accounts for thromboembolic complications. Here, we aimed to...
Autores principales: | Witkowski, Marco, Friebel, Julian, Tabaraie, Termeh, Grabitz, Sinah, Dörner, Andrea, Taghipour, Lena, Jakobs, Kai, Stratmann, Bernd, Tschoepe, Diethelm, Landmesser, Ulf, Rauch, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266708/ https://www.ncbi.nlm.nih.gov/pubmed/32940892 http://dx.doi.org/10.1007/s10557-020-07040-7 |
Ejemplares similares
-
MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
por: Witkowski, Marco, et al.
Publicado: (2018) -
Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
por: Witkowski, Marco, et al.
Publicado: (2016) -
Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
por: Witkowski, Marco, et al.
Publicado: (2020) -
Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011) -
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)